CD8A and neoplasm: We found that BAPN treatment alone significantly decreases the number of polymorphonuclear neutrophils (Figure 7B), but increases the presence of MHCII+ tumor-associated macrophages (TAMs) (Figure 7C), while the combination therapy expanded the percentage of GrzmB CD8+ T cells (Figure 7D) and the ratio of CD8+ to Treg cells (Figure 7E).